Abstract
Stem cell therapy is a promising approach for the treatment of tissue ischemia associated with myocardial infarction and peripheral arterial disease. Stem and progenitor cells derived from bone marrow or from pluripotent stem cells have shown therapeutic benefit in boosting angiogenesis as well as restoring tissue function. Notably, adult stem and progenitor cells including mononuclear cells, endothelial progenitor cells, and mesenchymal stem cells have progressed into clinical trials and have shown positive benefits. In this review, we overview the major classes of stem and progenitor cells, including pluripotent stem cells, and summarize the state of the art in applying these cell types for treating myocardial infarction and peripheral arterial disease.
| Original language | English |
|---|---|
| Pages (from-to) | H455-H465 |
| Journal | American Journal of Physiology - Heart and Circulatory Physiology |
| Volume | 310 |
| Issue number | 4 |
| DOIs | |
| State | Published - Feb 2016 |
| Externally published | Yes |
Keywords
- Angiogenesis
- Hindlimb ischemia
- Myocardial infarction
- Peripheral arterial disease
- Pluripotent stem cell
- Stem cell therapy